Vanguard Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,439,571
Closed -$218M 4644
2022
Q3
$218M Buy
1,439,571
+7,113
+0.5% +$1.08M 0.01% 1333
2022
Q2
$209M Buy
1,432,458
+10,732
+0.8% +$1.56M 0.01% 1399
2022
Q1
$169M Buy
1,421,726
+52,635
+4% +$6.24M ﹤0.01% 1649
2021
Q4
$189M Sell
1,369,091
-8,890
-0.6% -$1.23M ﹤0.01% 1648
2021
Q3
$191M Buy
1,377,981
+56,711
+4% +$7.88M ﹤0.01% 1638
2021
Q2
$128M Buy
1,321,270
+48,374
+4% +$4.7M ﹤0.01% 1862
2021
Q1
$87M Buy
1,272,896
+124,655
+11% +$8.52M ﹤0.01% 2025
2020
Q4
$98.4M Buy
1,148,241
+97,739
+9% +$8.38M ﹤0.01% 1842
2020
Q3
$68.3M Sell
1,050,502
-454,285
-30% -$29.5M ﹤0.01% 1861
2020
Q2
$110M Buy
1,504,787
+110,271
+8% +$8.06M ﹤0.01% 1624
2020
Q1
$47.5M Buy
1,394,516
+383,632
+38% +$13.1M ﹤0.01% 1888
2019
Q4
$55M Buy
1,010,884
+118,639
+13% +$6.46M ﹤0.01% 2062
2019
Q3
$37.2M Sell
892,245
-262,012
-23% -$10.9M ﹤0.01% 2207
2019
Q2
$50.5M Buy
1,154,257
+294,098
+34% +$12.9M ﹤0.01% 2097
2019
Q1
$44.3M Buy
860,159
+191,923
+29% +$9.88M ﹤0.01% 2151
2018
Q4
$24.7M Buy
668,236
+131,725
+25% +$4.87M ﹤0.01% 2357
2018
Q3
$20.1M Buy
536,511
+20,785
+4% +$780K ﹤0.01% 2575
2018
Q2
$20.4M Buy
515,726
+228,776
+80% +$9.04M ﹤0.01% 2556
2018
Q1
$7.39M Buy
286,950
+100,487
+54% +$2.59M ﹤0.01% 2972
2017
Q4
$5.03M Buy
186,463
+50,615
+37% +$1.37M ﹤0.01% 3136
2017
Q3
$5.08M Buy
135,848
+7,746
+6% +$290K ﹤0.01% 3113
2017
Q2
$3.2M Buy
+128,102
New +$3.2M ﹤0.01% 3243